Maslah, N., Kaci, N., Roux, B., Alexe, G., Marie, R., Pasquer, H., Verger, E., Oliveira, R. D. D., Culeux, C., Mlayah, B., Gauthier, N., Gonzales, F., Zhao, L., Ganesan, S., Gou, P., Ling, F., Soret-Dulphy, J., Parquet, N., Vainchenker, W., Raffoux, E., Padua, R. A., Giraudier, S., Marty, C., Plo, I., Lobry, C., Stegmaier, K., Puissant, A., Kiladjian, J., Cassinat, B., Benajiba, L. (2025). JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms. Nature Communications. https://doi.org/10.1038/s41467-025-60884-1